Skip to main content


Annals of Nuclear Medicine

Annals of Nuclear Medicine OnlineFirst articles

14.11.2019 | Original Article

The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients

Anal cancer is a rare malignancy, accounting for up to 0.5% of all tumors and 0.2% of all cancer death. 1 Most patients with anal cancer are diagnosed at a localized or locally advanced stage with only about 13% of patients with distant metastatic …

12.11.2019 | Original Article

The results of 394 consecutive cases of knee joint radiation synovectomy (radiosynoviorthesis) using 90Y

The therapeutic use of radionuclides in exudative synovitis dates back to 1952 [ 1 ]. The founding father, an Austrian doctor called Karl Fehlinger [ 2 ], used injections of gold isotopes in treatment of rheumatoid arthritis. Currently, radiation …

08.11.2019 | Original Article

Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early

Anti-resorptive-agent-related osteonecrosis of the jaw (ARONJ) can be caused by the use of anti-resorptive agents (e.g., zoledronic acid and denosumab), which are widely used to decrease the incidence of skeletal-related events in patients with …

30.10.2019 | Review Article

Nuclear oncology as seen by me in Japan: a historical review and future perspective

Since 1964 the author has seen and experienced the progress of nuclear medicine in Japan. The purpose of this review article is to trace the application of radiopharmaceuticals and instruments for the diagnosis of tumors and treatment of cancers …

28.10.2019 | Original Article

Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on 18F FDG-PET/CT

In 2017, 1,688,780 new cancer cases are projected to occur in the United States [ 1 ]. An estimated 600,920 Americans would die from cancer in 2017, with 84,590 male and 71,280 female Americans dying from lung cancer [ 1 ]. Lung cancer would be the …

Aktuelle Ausgaben

Über diese Zeitschrift

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine.

The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.

Free Open Access Publication Program - Submit your paper to ANM for this privilege!

Open Access (OA) publication is a good way to expose your article to many readers in the world. ANM may offer authors with charge free OA publication for high-quality articles. Upon acceptance of articles, OA publication in this program is considered according to the recommendation from the editor who manages the particular manuscript, and the editor-in-chief makes a final decision. The authors are noticed in the letter of acceptance if their article is selected for this offer.

Weitere Informationen